Tekmira Pharmaceuticals

Tekmira Pharmaceuticals is a Canadian company that is developing an experimental Ebola treatment.

TKM-Ebola
The treatment TKM-Ebola was being developed under a $140 million US Department of Defence contract. TKM-Ebola was in phase-1 trials, in July 2014 the US regulatory body placed it on hold due to safety concerns.

2014 outbreak
During the 2014 ebola outbreak their stock price rose significantly.